{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:15:29Z","timestamp":1793459729334,"version":"4.5.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T00:00:00Z","timestamp":1712016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Prevention of Alzheimer's Disease"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.14283\/jpad.2024.64","type":"journal-article","created":{"date-parts":[[2024,3,20]],"date-time":"2024-03-20T10:31:48Z","timestamp":1710930708000},"page":"529-536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["\u201cTime Saved\u201d Calculations to Improve Decision-Making in Progressive Disease Studies"],"prefix":"10.1016","volume":"11","author":[{"given":"S.P.","family":"Dickson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Haaland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.H.","family":"Mallinckrodt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Dubois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"O'Keefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"A.","family":"Fern\u00e1ndez Santana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achim","family":"Schneeberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Hendrix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.14283\/jpad.2024.64_bib1","first-page":"S109","article-title":"Disease-modifying approaches to Alzheimer's disease: Challenges and opportunities\u2014Lessons from donepezil therapy","volume":"4","author":"Sabbagh","year":"2008","journal-title":"Alzheimer's & Dementia"},{"key":"10.14283\/jpad.2024.64_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40035-017-0096-2","article-title":"Disease modification and Neuroprotection in neurodegenerative disorders","volume":"6","author":"Cummings","year":"2017","journal-title":"Translational Neurodegeneration"},{"issue":"6","key":"10.14283\/jpad.2024.64_bib3","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1080\/14737167.2020.1822738","article-title":"Challenges in demonstrating the value of disease-modifying therapies for Alzheimer's disease","volume":"20","author":"Gustavsson","year":"2020","journal-title":"Expert Review of Pharmacoeconomics & Outcomes Research"},{"key":"10.14283\/jpad.2024.64_bib4","doi-asserted-by":"crossref","first-page":"595","DOI":"10.14283\/jpad.2023.50","article-title":"\u2018Time saved' as a demonstration of clinical meaningfulness and illustrated using the Donanemab TRAILBLAZERALZ study findings","volume":"10","author":"Dickson","year":"2023","journal-title":"J Prev Alzheimers Dis"},{"issue":"1","key":"10.14283\/jpad.2024.64_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer's disease","volume":"388","author":"Van Dyck","year":"2023","journal-title":"New England Journal of Medicine"},{"key":"10.14283\/jpad.2024.64_bib6","doi-asserted-by":"crossref","first-page":"5537","DOI":"10.1002\/sim.9581","article-title":"Progression models for repeated measures: Estimating novel treatment effects in progressive diseases","volume":"41","author":"Raket","year":"2022","journal-title":"Statistics in Medicine"},{"key":"10.14283\/jpad.2024.64_bib7","first-page":"227","article-title":"A combined measure of cognition and function for clinical trials: the integrated Alzheimer's disease rating scale (iADRS)","volume":"2","author":"Wessels","year":"2015","journal-title":"J Prevent Alzheimers Dis"},{"key":"10.14283\/jpad.2024.64_bib8","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1080\/10543406.2017.1315819","article-title":"Statistical properties of continuous composite scales and implications for drug development","volume":"27","author":"Liu-Seifert","year":"2017","journal-title":"J Biopharm Stat"},{"issue":"9","key":"10.14283\/jpad.2024.64_bib9","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1136\/jnnp-2015-312383","article-title":"ADCOMS: A composite clinical outcome for prodromal Alzheimer's disease trials","volume":"87","author":"Wang","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.14283\/jpad.2024.64_bib10","first-page":"103","article-title":"Results from a phase II study to assess the clinical and immunological activity of AFFITOPE\u00ae AD02 in patients with early Alzheimer's disease","volume":"2","author":"Schneeberger","year":"2015","journal-title":"J Prevent Alzheimers Dis"},{"key":"10.14283\/jpad.2024.64_bib11","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2307\/2531158","article-title":"Procedures for comparing samples with multiple endpoints","author":"O'Brien","year":"1984","journal-title":"Biometrics"},{"issue":"1","key":"10.14283\/jpad.2024.64_bib12","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13195-020-00633-2","article-title":"The Alzheimer's Prevention Initiative Composite Cognitive Test: A practical measure for tracking cognitive decline in preclinical Alzheimer's disease","volume":"12","author":"Langbaum","year":"2020","journal-title":"Alzheimers Res Ther"},{"issue":"2","key":"10.14283\/jpad.2024.64_bib13","first-page":"91","article-title":"Methodological Aspects of the Phase II Study AFF006 Evaluating Amyloid-beta-Targeting Vaccine AFFITOPE\u00ae AD02 in Early Alzheimer's Disease - Prospective Use of Novel Composite Scales","volume":"2","author":"Hendrix","year":"2015","journal-title":"J Prev Alzheimers Dis"},{"issue":"5","key":"10.14283\/jpad.2024.64_bib14","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jalz.2016.01.002","article-title":"Longitudinal decline in mild-to-moderate Alzheimer's disease: Analyses of placebo data from clinical trials","volume":"12","author":"Thomas","year":"2016","journal-title":"Alzheimer's & Dementia"},{"issue":"2","key":"10.14283\/jpad.2024.64_bib15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.14283\/jpad.2022.30","article-title":"Two randomized phase 3 studies of aducanumab in early Alzheimer's disease","volume":"9","author":"Budd Haeberlein","year":"2022","journal-title":"J Prevent Alzheimers Dis"},{"key":"10.14283\/jpad.2024.64_bib16","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","author":"Sims","year":"2023","journal-title":"JAMA"}],"container-title":["The Journal of Prevention of Alzheimer's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724000451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2274580724000451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T02:08:00Z","timestamp":1737338880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2274580724000451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":16,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2274580724000451"],"URL":"https:\/\/doi.org\/10.14283\/jpad.2024.64","relation":{},"ISSN":["2274-5807"],"issn-type":[{"value":"2274-5807","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cTime Saved\u201d Calculations to Improve Decision-Making in Progressive Disease Studies","name":"articletitle","label":"Article Title"},{"value":"The Journal of Prevention of Alzheimer's Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.14283\/jpad.2024.64","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024 THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher. Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}